OraSure Technologies ROA 2006-2019 | OSUR

Current and historical return on assets (ROA) values for OraSure Technologies (OSUR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. OraSure Technologies ROA for the three months ending June 30, 2019 was 6.96%.
OraSure Technologies ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-06-30 $0.02B $0.33B 6.00%
2019-03-31 $0.02B $0.32B 6.17%
2018-12-31 $0.02B $0.32B 6.68%
2018-09-30 $0.02B $0.30B 5.77%
2018-06-30 $0.02B $0.29B 5.19%
2018-03-31 $0.02B $0.29B 5.70%
2017-12-31 $0.03B $0.30B 11.23%
2017-09-30 $0.03B $0.28B 12.23%
2017-06-30 $0.03B $0.26B 13.29%
2017-03-31 $0.03B $0.23B 13.73%
2016-12-31 $0.02B $0.21B 9.50%
2016-09-30 $0.02B $0.20B 8.71%
2016-06-30 $0.01B $0.20B 6.23%
2016-03-31 $0.01B $0.19B 5.33%
2015-12-31 $0.01B $0.19B 4.32%
2015-09-30 $0.00B $0.19B 0.00%
2015-06-30 $0.00B $0.18B 0.00%
2015-03-31 $0.00B $0.18B 0.54%
2014-12-31 $-0.01B $0.19B -2.72%
2014-09-30 $0.00B $0.19B 2.19%
2014-06-30 $0.00B $0.18B 0.56%
2014-03-31 $-0.01B $0.17B -3.94%
2013-12-31 $-0.01B $0.18B -6.13%
2013-09-30 $-0.02B $0.18B -12.69%
2013-06-30 $-0.02B $0.17B -12.37%
2013-03-31 $-0.02B $0.18B -12.66%
2012-12-31 $-0.02B $0.19B -9.40%
2012-09-30 $-0.01B $0.20B -6.26%
2012-06-30 $-0.01B $0.13B -8.78%
2012-03-31 $-0.01B $0.13B -7.24%
2011-12-31 $-0.01B $0.13B -7.33%
2011-09-30 $-0.01B $0.12B -8.23%
2011-06-30 $-0.01B $0.12B -4.95%
2011-03-31 $-0.01B $0.12B -4.10%
2010-12-31 $-0.00B $0.12B -3.27%
2010-09-30 $-0.01B $0.12B -4.86%
2010-06-30 $-0.00B $0.12B -3.20%
2010-03-31 $-0.01B $0.12B -6.43%
2009-12-31 $-0.01B $0.13B -6.35%
2009-09-30 $-0.03B $0.13B -26.72%
2009-06-30 $-0.04B $0.12B -28.15%
2009-03-31 $-0.04B $0.13B -24.05%
2008-12-31 $-0.03B $0.13B -20.03%
2008-09-30 $-0.00B $0.16B -1.22%
2008-06-30 $0.00B $0.16B 0.00%
2008-03-31 $0.00B $0.16B 1.84%
2007-12-31 $0.00B $0.17B 1.24%
2007-09-30 $0.00B $0.16B 1.89%
2007-06-30 $0.01B $0.16B 3.21%
2007-03-31 $0.01B $0.16B 3.28%
2006-12-31 $0.01B $0.16B 3.42%
2006-09-30 $0.03B $0.15B 17.92%
2006-06-30 $0.03B $0.15B 21.26%
2006-03-31 $0.03B $0.13B 23.74%
2005-12-31 $0.03B $0.13B 27.12%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.472B $0.182B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.167B 20.94
Abbott Laboratories (ABT) United States $147.719B 27.77
Stryker (SYK) United States $82.752B 28.62
Boston Scientific (BSX) United States $60.302B 29.25
Baxter (BAX) United States $44.623B 27.06
EssilorLuxottica Societe Anonyme (ESLOY) France $31.677B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.159B 18.66
Lonza Group Ag (LZAGY) Switzerland $25.836B 0.00
Coloplast (CLPBY) Denmark $25.785B 41.16
Terumo (TRUMY) Japan $23.720B 27.27
Smith & Nephew SNATS (SNN) United Kingdom $20.893B 0.00
ResMed (RMD) United States $19.328B 36.86
Sunny Optical Technology (SNPTF) China $16.573B 0.00
Bio-Rad Laboratories (BIO) United States $10.288B 55.15
Insulet (PODD) United States $9.390B 556.43
Canopy Growth (CGC) Canada $8.891B 0.00
Perrigo (PRGO) Ireland $7.516B 13.85
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.032B 20.96
Haemonetics (HAE) United States $6.572B 49.59
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.122B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.982B 0.00
Neogen (NEOG) United States $3.929B 65.23
NuVasive (NUVA) United States $3.473B 27.68
ICU Medical (ICUI) United States $3.302B 21.42
Hutchison China MediTech (HCM) China $2.696B 0.00
Quidel (QDEL) United States $2.660B 26.42
Agios Pharmaceuticals (AGIO) United States $2.133B 0.00
National Vision Holdings (EYE) United States $1.958B 42.25
Cardiovascular Systems (CSII) United States $1.782B 0.00
Aphria (APHA) $1.546B 0.00
VAREX IMAGING (VREX) United States $1.100B 25.34
Lantheus Holdings (LNTH) United States $1.024B 26.92
AtriCure (ATRC) United States $0.993B 0.00
Phibro Animal Health (PAHC) United States $0.907B 14.75
Omeros (OMER) United States $0.898B 0.00
NanoString Technologies (NSTG) United States $0.863B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 19.77
PetIQ (PETQ) United States $0.768B 18.15
Cerus (CERS) United States $0.748B 0.00
LeMaitre Vascular (LMAT) United States $0.699B 41.41
MacroGenics (MGNX) United States $0.630B 0.00
Surmodics (SRDX) United States $0.628B 119.36
Quanterix (QTRX) United States $0.610B 0.00
TG Therapeutics (TGTX) United States $0.573B 0.00
Meridian Bioscience (VIVO) United States $0.422B 13.16
BioLife Solutions (BLFS) United States $0.394B 129.63
Utah Medical Products (UTMD) United States $0.364B 26.64
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.360B 0.00
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.324B 34.45
United Health Products (UEEC) United States $0.258B 0.00
Bovie Medical (APYX) United States $0.249B 0.00
Rockwell Medical (RMTI) United States $0.209B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Chimerix (CMRX) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 10.20
Female Health (VERU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
United-Guardian (UG) United States $0.087B 20.48
Nephros (NEPH) United States $0.065B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.028B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00